TREM-2 promotes acquired cholesteatoma-induced bone destruction by modulating TLR4 signaling pathway and osteoclasts activation

Triggering receptor expressed on myeloid cells (TREM) has been broadly studied in inflammatory disease. However, the expression and function of TREM-2 remain undiscovered in acquired cholesteatoma. The expression of TREM-2 was significantly higher in human acquired cholesteatoma than in normal skin...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Sci Rep
Prif Awduron: Jiang, Huaili, Si, Yu, Li, Zhuohao, Huang, Xi, Chen, Suijun, Zheng, Yiqing, Xu, Guo, Chen, Ximing, Chen, Yubin, Liu, Yi, Xiong, Hao, Huang, Qiuhong, Liang, Maojin, Zhang, Zhigang
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Nature Publishing Group 2016
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5146948/
https://ncbi.nlm.nih.gov/pubmed/27934908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep38761
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg